BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17074682)

  • 1. p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas.
    Subramaniam MM; Noguera R; Piqueras M; Navarro S; López-Guerrero JA; Llombart-Bosch A
    Am J Clin Pathol; 2006 Dec; 126(6):866-74. PubMed ID: 17074682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
    Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
    Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
    In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
    Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
    Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
    Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
    Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
    West RB
    Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades.
    Chen Z; Huang X; Ye J; Pan P; Cao Q; Yang B; Li Z; Su M; Huang C; Gu J
    Cancer; 2010 Apr; 116(8):1953-63. PubMed ID: 20186824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p16INK4A expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected synovial sarcomas.
    Sabah M; Cummins R; Leader M; Kay E
    Virchows Arch; 2005 Nov; 447(5):842-8. PubMed ID: 16082560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genetic stability of the SYT gene rearrangement by break-apart FISH in primary and xenotransplanted synovial sarcomas.
    Subramaniam MM; Noguera R; Piqueras M; Navarro S; Carda C; Pellin A; López-Guerrero JA; Llombart-Bosch A
    Cancer Genet Cytogenet; 2007 Jan; 172(1):23-8. PubMed ID: 17175375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
    Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
    J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
    Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
    Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
    Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
    Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First case report of a fetal synovial sarcoma confirmed by molecular detection of SYT-SSX fusion gene transcripts.
    Duband S; Morrison AL; Pasquier D; Coindre JM; Pasquier B; Péoc'h M
    Am J Perinatol; 2008 Sep; 25(8):517-20. PubMed ID: 18720326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dual fluorescence in situ hybridization analysis of synovial sarcoma].
    Sápi Z; Antal I; Túri A; Szendröi M; Bodó M
    Orv Hetil; 1999 Nov; 140(48):2691-4. PubMed ID: 10645714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma.
    Savola S; Nardi F; Scotlandi K; Picci P; Knuutila S
    Cytogenet Genome Res; 2007; 119(1-2):21-6. PubMed ID: 18160777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.